Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 7.99%80.67M | 6.41%39.35M | 12.26%74.7M | 18.84%36.98M | 4.91%66.54M | -9.37%31.12M | -11.42%63.43M | -3.27%34.34M | -1.39%71.61M | -1.52%35.5M |
| Operating income | 7.99%80.67M | 6.41%39.35M | 12.26%74.7M | 18.84%36.98M | 4.91%66.54M | -9.37%31.12M | -11.42%63.43M | -3.27%34.34M | -1.39%71.61M | -1.52%35.5M |
| Cost of sales | -5.56%-67.08M | -3.23%-31.91M | -10.44%-63.55M | -14.23%-30.91M | -4.96%-57.55M | 3.57%-27.06M | 4.07%-54.83M | -5.06%-28.06M | -13.28%-57.16M | -9.37%-26.71M |
| Operating expenses | -5.56%-67.08M | -3.23%-31.91M | -10.44%-63.55M | -14.23%-30.91M | -4.96%-57.55M | 3.57%-27.06M | 4.07%-54.83M | -5.06%-28.06M | -13.28%-57.16M | -9.37%-26.71M |
| Gross profit | 21.87%13.58M | 22.59%7.45M | 23.95%11.15M | 49.50%6.07M | 4.61%8.99M | -35.28%4.06M | -40.51%8.6M | -28.59%6.28M | -34.78%14.45M | -24.39%8.79M |
| Administrative expenses | -4.71%-10.55M | -4.82%-4.83M | -16.60%-10.08M | -14.77%-4.61M | 13.60%-8.64M | 9.91%-4.02M | -17.51%-10.01M | -16.98%-4.46M | 22.18%-8.51M | -18.28%-3.81M |
| Special items of operating profit | -19.39%370K | 44.94%129K | 12.78%459K | -58.60%89K | 30.03%407K | 32.72%215K | 48.34%313K | 74.19%162K | 112.70%211K | --93K |
| Operating profit | 122.80%3.4M | 76.58%2.74M | 102.12%1.53M | 493.13%1.55M | 168.89%755K | -86.78%262K | -117.83%-1.1M | -60.93%1.98M | -35.66%6.15M | -39.64%5.07M |
| Financing cost | 42.13%-103K | 35.05%-63K | 12.32%-178K | 11.01%-97K | 26.18%-203K | 27.33%-109K | -3.00%-275K | -20.97%-150K | 36.58%-267K | 56.94%-124K |
| Earning before tax | 144.58%3.3M | 84.01%2.68M | 144.20%1.35M | 852.29%1.46M | 140.26%552K | -91.65%153K | -123.32%-1.37M | -62.98%1.83M | -35.62%5.88M | -39.03%4.95M |
| Tax | -33.46%-702K | -82.74%-561K | -583.12%-526K | -403.28%-307K | 66.23%-77K | 89.17%-61K | 70.54%-228K | 10.35%-563K | -120.51%-774K | -32.21%-628K |
| After-tax profit from continuing operations | 215.69%2.6M | 84.35%2.12M | 73.05%822K | 1,150.00%1.15M | 129.71%475K | -92.75%92K | -131.32%-1.6M | -70.63%1.27M | -41.86%5.11M | -43.46%4.32M |
| Earning after tax | 215.69%2.6M | 84.35%2.12M | 73.05%822K | 1,150.00%1.15M | 129.71%475K | -92.75%92K | -131.32%-1.6M | -70.63%1.27M | -41.86%5.11M | -43.46%4.32M |
| Minority profit | -207.58%-71K | -34.48%38K | 214.29%66K | 262.50%58K | 320.00%21K | 1,700.00%16K | 112.82%5K | 85.71%-1K | -143.75%-39K | 78.79%-7K |
| Profit attributable to shareholders | 252.65%2.67M | 90.66%2.08M | 66.52%756K | 1,336.84%1.09M | 128.30%454K | -94.02%76K | -131.18%-1.6M | -70.66%1.27M | -41.52%5.15M | -43.61%4.33M |
| Basic earnings per share | 225.00%0.0013 | 66.67%0.001 | 100.00%0.0004 | 0.0006 | 125.00%0.0002 | 0 | -130.77%-0.0008 | -72.73%0.0006 | -48.00%0.0026 | -56.86%0.0022 |
| Diluted earnings per share | 225.00%0.0013 | 66.67%0.001 | 100.00%0.0004 | 0.0006 | 125.00%0.0002 | 0 | -130.77%-0.0008 | -72.73%0.0006 | -48.00%0.0026 | -56.86%0.0022 |
| Currency Unit | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | -- |
| Auditor | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.